CLINICAL TRIAL / NCT06554795

First-in-human Study of DB-1419 for Advanced/Metastatic Solid Tumors

  • Interventional
  • Recruiting
  • NCT06554795

A Phase 1/2a, Multicenter, Open-Label, First in Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of DB-1419 in Participants With Advanced/Metastatic Solid Tumors

A Phase 1/2a First-in-Human Study of DB-1419 in Advanced/Metastatic Solid Tumors